Alex Kalomparis is the vice president of public affairs at Gilead Sciences. He is responsible for all communications and patient advocacy activities across Africa, Asia, Australia, Canada, Europe, Latin America, and the Middle East. Kalomparis has held senior communication roles with a number of consumer and pharmaceutical companies including Unilever, Rolls Royce, Novartis, Roche, Astrazeneca, and GlaxoSmithKline.
The UNAIDS 2020 targets have been derailed by a public health crisis, but there are opportunities to work closer together. Alex Kalomparis of Gilead Sciences suggests looking beyond our own backyards to share solutions to fight the epidemic.